Remove Doctors Remove Treatment Remove Virus
article thumbnail

Soleno sales of new Prader-Willi drug rise faster than expected

BioPharma Drive: Drug Pricing

Spencer Platt via Getty Images The first marketed treatment for the insatiable hunger associated with Prader-Willi disease is selling more quickly than Wall Street analysts expected, an early, but encouraging sign of demand.

Drugs 243
article thumbnail

Simple test for flu could improve diagnosis and surveillance

Broad Institute

Simple test for flu could improve diagnosis and surveillance By Allessandra DiCorato June 18, 2024 Breadcrumb Home Simple test for flu could improve diagnosis and surveillance A low-cost CRISPR-based paper strip test distinguishes between influenza types and can be reprogrammed to recognize different viruses including the H5N1 bird flu virus.

Virus 144
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

COVID-19 patients are experiencing long-term effects from the virus

The Pharma Data

Almost a third of doctors have treated patients for long-term symptoms caused by coronavirus, according to a new study. A further 21% of 1,030 doctors who had since recovered from the virus reported chronic fatigue, while 11% said they had no concentration difficulties. Photo by Mohsen Atayi. Conor Kavanagh. Source link.

Virus 52
article thumbnail

Coronavirus: 'Long Covid' patients need treatment programme, doctors say

The Pharma Data

.” File on 4 asked all 212 Clinical Commissioning Groups (CCGs) and health boards across the UK whether they had set up post-Covid clinics for patients who were not admitted hospital with the virus – but did not necessarily receive a positive test result. A further 16 said they were planning or redesigning services.

Doctors 52
article thumbnail

Can a heartburn drug help doctors treat COVID-19?

The Pharma Data

In the early days of the COVID-19 pandemic, doctors in Wuhan noticed something surprising. Many of the elderly patients who survived the virus were poor: not exactly the demographic you would expect to fare well in a health crisis. But in more severe illnesses, cytokine production can spiral out of control, becoming dysregulated.

Doctors 52
article thumbnail

What FDA’s Newest Gene Therapy Approval Tells Us About Durability: How Long is Long Enough?

FDA Law Blog: Drug Discovery

Valentine — On November 22, 2022, FDA approved CSL Behring’s BLA for Hemgenix (etranacogene dezaparvovec), an AAV-based gene therapy for the treatment of adults with Hemophilia B who currently use Factor IX prophylaxis therapy, have current or historical life-threatening hemorrhage, or have repeated, serious spontaneous bleeding episodes.

Therapies 119
article thumbnail

Coronavirus doctor's diary: Trying out tech that may help make worship Covid-secure

The Pharma Data

He picked up the virus right at the start of the pandemic and had a relentless and gruelling illness followed by a lingering debilitation that has lasted over six months. Or read the previous online diary entry: Will universities be able to avoid spreading the virus? Front line diary. Image copyright. Ian Beesley. Source link.

Doctors 52